SCHEMBL9385441

SCHEMBL9385441

Cc1[nH]c(=O)c2cc3nc(-c4ccncc4)[nH]c3cc2c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
RAB9A P51151 1/20 0.53
ALDH1A1 P00352 4/20 0.51
HPGD P15428 4/20 0.51
KDM4E B2RXH2 3/20 0.51
HSD17B10 Q99714 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RHEB Q15382 1/20 0.51
MAPT P10636 1/20 0.50
ALOX15 P16050 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
PDE3B Q13370 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9379210 0.84 NPC1 (0.55) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL9704460 0.84 ALDH1A1 (0.59) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL9378150 0.75 ALDH1A1 (0.62) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL24075259 0.74 GUSB (0.76) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL9703633 0.73 PDGFRB (0.36) NPC1RAB9AKDM4EHSD17B10PDE3B
SCHEMBL9679534 0.73 NPC1 (0.67) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL9385123 0.73 ALDH1A1 (0.52) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL10700314 0.72 AMY1A (0.48) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL9381752 0.72 ALDH1A1 (0.55) NPC1RAB9AALDH1A1HPGDKDM4E
SCHEMBL9678498 0.72 ALDH1A1 (0.62) NPC1RAB9AALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US claimed
EP-0275888-B1 Tricyclic benzimidazoles, process for their preparation and use as medicaments BOEHRINGER MANNHEIM GMBH (DE) 1994-04-06 EP disclosed
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
US-4954498-A HYPOTENSIVE AGENTS, ANTICOAGULANTS, CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1990-09-04 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed